Clinical aspects of microbleeds in Alzheimer's disease

被引:13
|
作者
van der Flier, Wiesje M. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Dept Neurol, NL-1081 HZ Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr PK 1 Z 44, Dept Epidemiol & Biostat, NL-1081 HZ Amsterdam, Netherlands
关键词
Microbleeds; Alzheimer's disease; Mild cognitive impairment; Cognition; Microhemorrhage; CEREBRAL MICROBLEEDS; COGNITIVE FUNCTION;
D O I
10.1016/j.jns.2012.07.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Microbleeds are small lesions, appearing as black dots on T2*-weighted magnetic resonance imaging. They occur frequently in Alzheimer's disease (AD), but the clinical relevance of these radiological observations remains unclear. In this paper an overview is given on currently available evidence on the clinical relevance of microbleeds in AD. The evidence linking microbleeds to severity of cognitive impairment in AD is not unambiguous. From the existing literature, it seems reasonable to conclude that multiple microbleeds negatively impact cognitive performance, but there is less consensus on the importance of location of microbleeds in this respect. Regarding progression of disease, there is hardly any evidence that microbleeds affect disease course in terms of progression to AD in patients with MCl or with respect to rate of cognitive decline in AD patients. This may imply that microbleeds simply do not affect disease course, but an alternative explanation for the negative findings would be that these studies are hampered by selective drop-out, as individuals with many microbleeds have an increased risk of (stroke-related) mortality. (C) 2012 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:56 / 58
页数:3
相关论文
共 50 条
  • [41] Vascular aspects in Alzheimer's disease
    Skoog, I
    ADVANCES IN DEMENTIA RESEARCH, 2000, : 37 - 43
  • [42] Genetic aspects of Alzheimer's disease
    Zekanowski, C
    Religa, D
    Graff, C
    Filipek, S
    Kuznicki, J
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 19 - 31
  • [43] Vascular aspects in Alzheimer's disease
    Skoog, I
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2000, (59): : 37 - 43
  • [44] Neurobiological aspects of Alzheimer's disease
    Chopra, Kanwaljit
    Misra, Shubham
    Kuhad, Anurag
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 535 - 555
  • [45] Immunological aspects of Alzheimer's disease
    Wojtera, Marcin
    Kloszewska, Iwona
    Sobow, Tomasz
    Liberski, Pawe P.
    AKTUALNOSCI NEUROLOGICZNE, 2006, 6 (02): : 108 - 115
  • [46] Inflammatory aspects of Alzheimer's disease
    Lucena, Pablo Botella
    Heneka, Michael T.
    ACTA NEUROPATHOLOGICA, 2024, 148 (01)
  • [47] Incidence of cerebral microbleeds in preclinical Alzheimer disease
    Yates, Paul A.
    Desmond, Patricia M.
    Phal, Pramit M.
    Steward, Christopher
    Szoeke, Cassandra
    Salvado, Olivier
    Ellis, Kathryn A.
    Martins, Ralph N.
    Masters, Colin L.
    Ames, David
    Villemagne, Victor L.
    Rowe, Christopher C.
    NEUROLOGY, 2014, 82 (14) : 1266 - 1273
  • [48] Altered circadian cortisol secretion in Alzheimer's disease: Clinical and neuroradiological aspects
    Giubilei, F
    Patacchioli, FR
    Antonini, G
    Monti, MS
    Tisei, P
    Bastianello, S
    Monnazzi, P
    Angelucci, L
    JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (02) : 262 - 265
  • [49] Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease
    Sheikh-Bahaei, Nasim
    Manavaki, Roido
    Sajjadi, S. Ahmad
    Priest, Andrew N.
    O'Brien, John T.
    Gillard, Jonathan H.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (04) : 1489 - 1497
  • [50] Distribution preponderance of cerebral microbleeds according to severity of leukoaraiosis in Alzheimer's disease
    Park, M.
    Shin, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405